<DOC>
	<DOCNO>NCT02634216</DOCNO>
	<brief_summary>The purpose 12 week longitudinal study test effect dietary supplement , Capros , blood glycemic index Type 1 diabetic sensor provide continuous glucose monitoring ( CGM ) . 20 Type 1 Diabetics take Capros supplement 12 week determine effect blood glycemic index . Capros , generally safe dietary supplement currently sell counter United States . Type 1 diabetes also know juvenile diabetes commonly diagnosed child young adult . Insulin convert energy need daily living , diabetes , insulin produce body cause many problem . In traditional Indian medicine , gooseberry Phyllanthus emblica use thousand year effective source polyphenols antioxidant . A 12 week longitudinal study determine effect dietary supplement , Capros , blood glycemic index patient Type 1 diabetes ( T1D ) .</brief_summary>
	<brief_title>Effects Capros Patients With Type-1 Diabetes</brief_title>
	<detailed_description>There total 4 study visit , course 12 week . These visit occur week 1 , 4 , 8 , 12 . At study visit follow record : Age , Sex , Pulse , height , weight , CGM real time measurement follow non-medical information record : Address , Phone number Email address ( record first visit ask anything change reoccurring visit ) . The following happen visit : Visit 1 ( Week 0 ) : The subject present informed consent . Data collect data collection sheet , finger stick A1C obtain ( complete SoC ) , Continuous Glucose Monitoring download , UPT WCBP perform , subject give 4-week supply Capros supplement subject diary . The subject give subject diary document morning/evening sugar time participant take supplement . The subject ask bring diary follow-up visit check compliance verification . Visit 2 3 ( Week 4 8 ) : The following activity take place visit : AE review , concomitant medication review , weight , vital sign , CGM download , pill count distribution , collect previous diary provide new . Visit 4 ( Week 12 ) : The following activity take place visit : AE review , concomitant medication review , weight , vital sign , CGM download , pill count , collect previous diary . Also , visit , finger stick A1C ( complete SoC ) , distribution supplement . Taking supplement : After receive supplement , subject instruct take 2 capsule per day mouth , food around lunchtime food around dinner time total 12 week . The subject ask keep empty bottles/ remain Capros supplement bring follow-up visit compliance check . Participants receive new 4-week supply supplement study visit 2 3 . Risks participate study extremely low . Capros dietary supplement derive Indian Gooseberry , contain artificial ingredient , non-toxic safely tolerate among human . Capros currently sell counter U.S. known side effect ; however allergic reaction supplement possible . There potential risk hypoglycemia take supplement . In even occurs , subject instruct follow primary care physician instruction record data log . This treatment study subject may direct benefit take supplement . The investigator look monitor observe change take place participant blood sugar level course study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Subjects must 10 60 yr . age Type 1 Diabetes use Continuous Glucose Monitoring ( CGM ) least last 3 month Less 10 % variation prescribe long act dosage previous 3 month Individuals deem unable understand procedure , risk benefit study , i.e . informed consent exclude study Females pregnant Individuals therapeutically immunocompromised Prisoners Anyone know allergy amla fruit Current use follow medication result exclusion : Steroids ( Prednisone , etc . ) Immunosuppressants Accutane ( last 6 month )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hyperglycemia</keyword>
	<keyword>Capros</keyword>
	<keyword>Type 1 Diabetes</keyword>
</DOC>